Neusdruppels Xylometazoline Hcl Etos (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride acts on the nasal mucosa to reduce swelling and improve airflow in several upper‑respiratory conditions.

• Nasal congestion due to common cold: provides rapid, temporary relief of blocked nasal passages.
• Sinusitis: helps decrease mucosal edema, facilitating sinus drainage.
• Allergic rhinitis: reduces nasal obstruction caused by allergic inflammation.

• Xylometazoline Hydrochloride selectively stimulates alpha‑adrenergic receptors on the vascular smooth muscle of the nasal mucosa. This activation triggers vasoconstriction, which reduces blood flow and edema in the nasal tissues, leading to decreased congestion and improved airway patency.

Adverse reactions may occur with any nasal decongestant and are generally related to local irritation or systemic sympathomimetic activity.

Common Side Effects

• Nasal irritation or burning sensation
• Dryness of the nasal mucosa
• Sneezing
• Headache
• Bitter taste or altered sense of smell
• Mild epistaxis (nosebleed)

Serious or Rare Side Effects

• Hypertension or elevated blood pressure
• Tachycardia or arrhythmia
• Severe nasal ulceration or perforation
• Allergic reaction (rash, itching, swelling)
• Rebound congestion (rhinitis medicamentosa) with prolonged use
• Central nervous system effects such as dizziness or anxiety

Before using Neusdruppels Xylometazoline Hcl Etos, consider the following safety measures.

• Duration of use: limit application to no more than 3–5 consecutive days to avoid rebound congestion.
• Cardiovascular conditions: use with caution in patients with hypertension, coronary artery disease, or arrhythmias.
• Thyroid disease: monitor closely if the patient has hyperthyroidism.
• Pregnancy and breastfeeding: consult a healthcare professional before use.
• Children: avoid use in children under the age recommended by the prescriber.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Xylometazoline may interact with other sympathomimetic agents or medications affecting blood pressure.

Major Interactions (Avoid)

• Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis.
• Non‑selective beta‑blockers: may blunt the decongestant effect and increase blood pressure.
• Other nasal decongestants: combined use can amplify systemic sympathomimetic effects.

Moderate Interactions (Monitor Closely)

• Antihypertensive drugs (ACE inhibitors, ARBs): may reduce their efficacy.
• Tricyclic antidepressants: potential additive cardiovascular stimulation.
• Stimulants (e.g., caffeine, pseudoephedrine): monitor for increased heart rate or blood pressure.